Thermoregulatory and endocrine effects of a low dose of danazol in postmenopausal women: Interaction with the effect of naloxone
article
OA: green
CC0
AI-generated summary
This study investigated the thermoregulatory and endocrine effects of a low dose of danazol, examining its interaction with naloxone's effects in postmenopausal women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Before and on the 30th day of danazol administration (200 mg/day), in six postmenopausal women the activity of endogenous opioid peptides has been indirectly evaluated by the effect on LH secretion and body temperature (measured as rectal temperature) exerted by the infusion of the opioid antagonist naloxone (1.6 mg/h x 4 h preceded by 1.6 mg iv bolus). Before and during danazol administration a GnRH test (100 mcg iv bolus) was also performed to evaluate possible variations in pituitary responsiveness to GnRH. Danazol significantly reduced mean plasma levels of LH and FSH (p less than 0.01), and their response to GnRH stimulus (p less than 0.05). Either before or during danazol administration mean plasma LH and FSH levels did not vary during the infusion of naloxone, while body temperature significantly decreased (p less than 0.01). The decrease in body temperature was significantly greater (p less than 0.05) during danazol than before treatment. The present data suggest that in postmenopausal women a low dose of danazol exerts an antigonadotropic effect mainly reducing the pituitary responsiveness to GnRH. The enhanced hypothermic response to naloxone observed during danazol administration also seems to suggest that in postmenopausal women a low dose of danazol enhances the thermoregulatory role of endogenous opioid peptides.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (43)
- Danazol binding and translocation of steroid receptors via openalex
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity via openalex
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro via openalex
- Danazol: Endocrine consequences in healthy women via openalex
- Danazol inhibits steroidogenesis by the human ovary in vivo via openalex
- Danazol suppression of luteinizing hormone secretion: a role for danazol-androgen receptor interaction within the brain-pituitary complex via openalex
- EFFECT OF DANAZOL ON SERUM GONADOTROPHINS AND STEROID HORMONE CONCENTRATIONS IN WOMEN WITH MENORRHAGIA via openalex
- Effects of danazol on gonadal steroidogenesis in patients with a complete form of testicular feminization via openalex
- Effects of danazol on gonadotropin levels in castrated rhesus monkeys. via openalex
- Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women via openalex
- Effects of danazol on steroidogenesis and gonadotropic responsiveness in isolated human preovulatory follicular cells via openalex
- Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3′,5′ cyclic monophosphate formation via openalex
- Hormonal changes associated with Danazol therapy. via openalex
- Hot flashes in postmenopausal women ameliorated by danazol via openalex
- Influence of danazol treatment during the luteal phase on pituitary and ovarian function during the subsequent menstrual cycle via openalex
- Inhibition of gonadotropin-releasing hormone receptors in rat anterior pituitary monolayer cell cultures by danazol via openalex
- Inhibitory effects of danazol on steroidogenesis in cultured human granulosa cells via openalex
- LRF and TRF test during long-term danazol treatment: increase of the LH and FSH responses but decrease of the prolactin and TSH responses via openalex
- SELECTIVE INHIBITION BY DANAZOL OF FOLLICLE STIMULATING HORMONE DURING THE LUTEAL PHASE via openalex
- Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component* via openalex
- The Effect of Danazol on Anterior Pituitary Function via openalex
- The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle via openalex
- doi:10.1016/0361-9230(87)90169-9 via openalex
- doi:10.1210/jcem-60-1-34 via openalex
- W2061541231 via openalex
- doi:10.1016/s0022-3565(25)31081-5 via openalex
- doi:10.1111/j.1365-2265.1985.tb03243.x via openalex
- doi:10.1210/jcem-51-1-179 via openalex
- doi:10.1016/s0015-0282(16)46137-6 via openalex
- doi:10.1210/jcem-66-5-964 via openalex
- doi:10.1210/endo-104-5-1286 via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
- doi:10.1016/0024-3205(86)90294-8 via openalex
- doi:10.1210/jcem-57-5-881 via openalex
- doi:10.1016/s0015-0282(16)43869-0 via openalex
- doi:10.1210/endo-93-4-893 via openalex
- doi:10.1016/0014-2999(76)90253-3 via openalex
- doi:10.1159/000124907 via openalex
- doi:10.1016/0024-3205(89)90397-4 via openalex
- doi:10.1016/0091-3057(86)90517-4 via openalex
- doi:10.1172/jci111417 via openalex
- doi:10.1016/0024-3205(88)90096-3 via openalex
- doi:10.1159/000123956 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T05:37:28.352103+00:00
License: CC0
· commercial use OK